Related Experiment Video
Updated: Jun 13, 2025
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.1K
A Randomized Controlled Trial on Automated Vehicle Technologies for Drivers With Parkinson's Disease.
Sherrilene Classen1, Wayne C W Giang1, Albraa Rajkhan1
1University of Florida, Gainesville, USA.
OTJR : Occupation, Participation and Health
|September 12, 2024
Summary
In-vehicle information systems (IVIS) and advanced-driver assistance systems (ADAS) improve driving safety for individuals with Parkinson's disease (PD). These technologies reduce driving errors, though memory impairments remain a challenge.
Area of Science:
- Neurology
- Human-Computer Interaction
- Transportation Safety
Background:
- Parkinson's disease (PD) significantly impairs driving ability.
- Limited research exists on the effectiveness of in-vehicle information systems (IVIS) and advanced-driver assistance systems (ADAS) for PD drivers.
Purpose of the Study:
- To quantify the impact of IVIS and ADAS on on-road driving errors in individuals with PD.
- To investigate how specific PD symptoms correlate with driving errors when using these systems.
Main Methods:
- 107 drivers with PD operated a vehicle equipped with IVIS and ADAS in real-world traffic conditions.
- Driving errors were systematically recorded and analyzed.
- Correlations between specific motor and cognitive impairments and driving errors were examined.
Main Results:
- Activation of IVIS and ADAS led to a significant reduction in overall driving errors for PD drivers.
- Adaptive cruise control specifically decreased speeding errors on highways.
- Bradykinesia correlated with errors when systems were off; memory impairments correlated with errors when systems were on.
- Executive function and visuospatial deficits were linked to more errors during system deactivation.
Conclusions:
- IVIS and ADAS effectively reduce driving errors in individuals with Parkinson's disease.
- These technologies help mitigate the impact of individual driving variations caused by PD.
- Cognitive decline, particularly memory impairment, presents a challenge for the effective use of IVIS and ADAS in PD patients.
Related Concept Videos
01:24Parkinson's Disease: Treatment
237
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
237
01:15Parkinson's Disease: Overview
498
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
498